Murat Cokol

Systematic exploration of synergistic drug pairs.

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.

Drugs and their interactions.

Oxidative stress is a mediator for increased lipid accumulation in a newly isolated Dunaliella salina strain.

Large-scale identification and analysis of suppressive drug interactions.

A drug similarity network for understanding drug mechanism of action.

Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution.

Target-independent prediction of drug synergies using only drug lipophilicity.

Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives.

Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.

Chemogenomics and orthology-based design of antibiotic combination therapies.

Temporal and intrinsic factors of rifampicin tolerance in mycobacteria.

Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.

Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.

Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery.

Efficient measurement and factorization of high-order drug interactions in .